LENZ Therapeutics, Inc. (LENZ)

Corporate Overview

LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision, proudly based in San Diego. Our lead program is an aceclidine based eye drop designed to restore the loss of near vision associated with presbyopia.

Our Leadership

Latest Financial Results

Q1 2024

Quarter Ended Mar 31, 2024

Earnings Release PDF

Earnings Webcast

10-Q PDF

XBRL

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2023

Latest News

May 8, 2024 • 4:01 PM EDT

LENZ Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

View Press Release View All News

Recent Event

May 8, 2024 4:30 pm EDT

Lenz Therapeutics First Quarter 2024 Financial Results and Business Update

View Event View All Events

Email Alerts

Get the latest news and reports delivered right to your inbox.

IR Contacts

Corporate

LENZ Therapeutics, Inc.
445 Marine View Ave.
Suite 320
Del Mar, CA 92014
T: 858-925-7000
contact@lenz-tx.com

Investor Relations

LENZ Therapeutics
IR@LENZ-Tx.com

Stern Investor Relations, Inc.
Janhavi Mohite
janhavi.mohite@sternir.com

Transfer Agent

Equiniti Trust Company, LLC
48 Wall Street
New York, NY 10005
T: 800-937-5449